{"id":"NCT01391273","sponsor":"Allergan","briefTitle":"Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis","officialTitle":"A Multicenter, Double-masked, Randomized, Parallel-group Study Assessing the Safety and Efficacy of Once-Daily Application of Bimatoprost Solution 0.03% Compared to Vehicle in Increasing Overall Eyelash Prominence in Japanese Subjects With Hypotrichosis of the Eyelashes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-07-01","primaryCompletion":"2012-05-19","completion":"2012-05-19","firstPosted":"2011-07-12","resultsPosted":"2013-07-09","lastUpdate":"2019-07-08"},"enrollment":173,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Eyelash Hypotrichosis"],"interventions":[{"type":"DRUG","name":"bimatoprost solution 0.03%","otherNames":["LATISSEÂ®"]},{"type":"DRUG","name":"bimatoprost vehicle solution","otherNames":[]}],"arms":[{"label":"bimatoprost solution 0.03%","type":"EXPERIMENTAL"},{"label":"bimatoprost vehicle solution","type":"PLACEBO_COMPARATOR"}],"summary":"This study will evaluate the safety and efficacy of bimatoprost solution 0.03% compared with vehicle in Japanese adults with hypotrichosis of the eyelashes.","primaryOutcome":{"measure":"Percentage of Participants With at Least a 1-Grade Increase in Overall Eyelash Prominence Using the Global Eyelash Assessment Scale (GEA)","timeFrame":"Baseline, Month 4","effectByArm":[{"arm":"Bimatoprost Solution 0.03%","deltaMin":77.3,"sd":null},{"arm":"Bimatoprost Vehicle Solution","deltaMin":17.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":6},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":["24643895"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":87},"commonTop":["Nasopharyngitis"]}}